Testing Dyanavel XR for fatigue in adults with ADHD
Part of Mental health clinical trials.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have been diagnosed with ADHD and have moderate to severe symptoms (score over 36 on an ADHD rating scale).
- You have significant fatigue that interferes with your daily life (score over 3 on a fatigue scale).
- You live in Michigan or within a 50-mile drive of the study site in Michigan.
- You are not currently taking any stimulant medication for ADHD and have not taken any for at least 3 months.
- You do not have serious heart disease, a history of seizures, or other unstable medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
This trial tests health and wellness products to see if they can improve fatigue and related health outcomes. You won't know if you're taking the real product or a placebo until the study ends.
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
This study tests whether a wellness product can help improve fatigue and related health issues. You'll take either the real product or a placebo (a pill with no active ingredients) to see if it makes a difference.
This trial studies how your brain responds when you feel mentally and physically tired, using trained healthy volunteers. It may help researchers understand fatigue better, which could guide future treatments for people who struggle with fatigue.
This study tests a new medicine, HBS-301, for people with narcolepsy type 1 or type 2 who still have excessive daytime sleepiness. If you take other medications for sleepiness or mood, they must be stable for at least 3 months, and you cannot take some as-needed sleepiness medicines.
Hear when a new Fatigue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.